Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency

Lancet Diabetes Endocrinol. 2018 Apr;6(4):269-270. doi: 10.1016/S2213-8587(18)30045-7.

Authors

Sirazum Choudhury¹, Tricia Tan², Karim Meeran³

Affiliations

¹ Department of Clinical Biochemistry, Imperial College Healthcare NHS Trust, London, UK.
² Department of Investigative Medicine, Imperial College London, London, UK.
³ Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK. Electronic address: [email protected].

PMID: 29571508
DOI: 10.1016/S2213-8587(18)30045-7

No abstract available

Publication types

Letter
Kommentar

MeSH terms

Adrenal Hyperplasia, Congenital
Adrenal Insufficiency*
Humans
Hydrocortisone*

Substances

Hydrocortisone

Grants and funding

DRF-2017-10-115/DH_/Department of Health/United Kingdom